Ebola -- Liberia
rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus [VSV]-based candidate vaccine expressing a surface glycoprotein of _Zaire ebolavirus_. We tested the effect of rVSV-ZEBOV in preventing Ebola virus disease [EVD] in contacts and contacts of contacts of recently confirmed cases in Guinea, West Africa.
Interpretation
--------------
The results add weight to the interim assessment that rVSV-ZEBOV offers substantial protection against EVD, with no cases among
Read more about it at HealthMap Global Disease Alerts via http://bit.ly/2hIYZKj
No comments:
Post a Comment